{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:03:11Z","timestamp":1790200991558,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 20H03428"],"award-info":[{"award-number":["JP 20H03428"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H03532"],"award-info":[{"award-number":["JP19H03532"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jphs.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T09:46:06Z","timestamp":1645350366000},"page":"358-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A machine learning model that emulates experts\u2019 decision making in vancomycin initial dose planning"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-5473","authenticated-orcid":false,"given":"Tetsuo","family":"Matsuzaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Mizoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyofumi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jphs.2022.02.005_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatr","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Heal Pharm"},{"issue":"4","key":"10.1016\/j.jphs.2022.02.005_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000343162","article-title":"Is peak concentration needed in therapeutic drug monitoring of vancomycin? a pharmacokinetic-pharmacodynamic analysis in patients with methicillin- resistant staphylococcus aureus pneumonia","volume":"58","author":"Suzuki","year":"2012","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1016\/j.jphs.2022.02.005_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkl030","article-title":"Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia","volume":"57","author":"Sakoulas","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jphs.2022.02.005_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Heal Pharm"},{"issue":"4","key":"10.1016\/j.jphs.2022.02.005_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"The American Thoracic Society, The Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jphs.2022.02.005_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1248\/bpb.b19-00729","article-title":"A\u00a0new algorithm optimized for initial dose settings of vancomycin using machine learning","volume":"43","author":"Imai","year":"2020","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"10.1016\/j.jphs.2022.02.005_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jiac.2019.11.009","article-title":"Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study","volume":"26","author":"Oda","year":"2020","journal-title":"J\u00a0Infect Chemother"},{"issue":"5","key":"10.1016\/j.jphs.2022.02.005_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2125.2010.03736.x","article-title":"Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline","volume":"70","author":"Marqu\u00e9s-Mi\u00f1ana","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jphs.2022.02.005_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4212\/cjhp.v65i3.1140","article-title":"Development and validation of a novel vancomycin dosing nomogram for achieving high-target trough levels at 2 Canadian teaching hospitals","volume":"65","author":"Thalakada","year":"2012","journal-title":"Can J Hosp Pharm"},{"issue":"10","key":"10.1016\/j.jphs.2022.02.005_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2019.02.029","article-title":"Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting","volume":"25","author":"Broeker","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.jphs.2022.02.005_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/ajhp\/zxz070","article-title":"Readiness to implement vancomycin monitoring based on area under the concentration-time curve: a cross-sectional survey of a national health consortium","volume":"76","author":"Kufel","year":"2019","journal-title":"Am J Heal Pharm"},{"issue":"9","key":"10.1016\/j.jphs.2022.02.005_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203453","article-title":"Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus","volume":"13","author":"Komoto","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jphs.2022.02.005_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000440607","article-title":"Safety and outcome of pharmacy-led vancomycin dosing and monitoring","volume":"61","author":"Momattin","year":"2015","journal-title":"Chemotherapy"},{"issue":"1","key":"10.1016\/j.jphs.2022.02.005_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-019-0148-3","article-title":"Artificial intelligence and machine learning in clinical development: a translational perspective","volume":"2","author":"Shah","year":"2019","journal-title":"npj Digit Med"},{"issue":"2","key":"10.1016\/j.jphs.2022.02.005_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jphs.2017.01.003","article-title":"Machine learning-based prediction of adverse drug effects: an example of seizure-inducing compounds","volume":"133","author":"Gao","year":"2017","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.jphs.2022.02.005_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.jphs.2022.02.005_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jphs.2019.03.004","article-title":"Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters","volume":"140","author":"Oyaga-Iriarte","year":"2019","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2022.02.005_bib18","first-page":"1","article-title":"Prediction of vancomycin dose on high-dimensional data using machine learning techniques","author":"Huang","year":"2021","journal-title":"Expet Rev Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.jphs.2022.02.005_bib19","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/jac\/dky310","article-title":"Dosing vancomycin in the super obese: less is more","volume":"73","author":"Crass","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jphs.2022.02.005_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijantimicag.2011.12.011","article-title":"Augmented renal clearance in septic patients and implications for vancomycin optimisation","volume":"39","author":"Baptista","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.jphs.2022.02.005_bib21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2125.2006.02807.x","article-title":"Assessment of renal function in clinical practice at the bedside of burn patients","volume":"63","author":"Conil","year":"2007","journal-title":"Br J Clin Pharmacol"},{"issue":"3 SUPPL. 2","key":"10.1016\/j.jphs.2022.02.005_bib22","article-title":"Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients","volume":"77","author":"Akers","year":"2014","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.jphs.2022.02.005_bib23","volume":"vol. 42","author":"Izumisawa","year":"2019"},{"key":"10.1016\/j.jphs.2022.02.005_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-019-02657-6","article-title":"The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adults","author":"Bury","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jphs.2022.02.005_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jphs.2014.12.003","article-title":"Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia","volume":"127","author":"Jaruratanasirikul","year":"2015","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2022.02.005_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Pavlov","year":"2001","journal-title":"Mach Learn"},{"key":"10.1016\/j.jphs.2022.02.005_bib27","first-page":"1","article-title":"Tunability: importance of hyperparameters of machine learning algorithms","volume":"20","author":"Probst","year":"2019","journal-title":"J\u00a0Mach Learn Res"},{"key":"10.1016\/j.jphs.2022.02.005_bib28","first-page":"338","article-title":"A\u00a0study of cross-validation and bootstrap for accuracy estimation and model selection","author":"Kohavi","year":"1995","journal-title":"Proc 14th Int Jt Conf Artif Intell"},{"issue":"4","key":"10.1016\/j.jphs.2022.02.005_bib29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jphs.2022.02.005_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02042-17","article-title":"Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing","volume":"62","author":"Neely","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jphs.2022.02.005_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11095-021-03030-y","article-title":"Performance of area under the concentration-time curve estimations of vancomycin with limited sampling by a newly developed web application","volume":"38","author":"Oda","year":"2021","journal-title":"Pharm Res (N Y)"},{"issue":"9","key":"10.1016\/j.jphs.2022.02.005_bib32","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.2010.35","article-title":"Recent changes in vancomycin use in renal failure","volume":"77","author":"Vandecasteele","year":"2010","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jphs.2022.02.005_bib33","first-page":"85","article-title":"Impact of learning set quality and size","volume":"1","author":"Sebban","year":"2000","journal-title":"Int J Comput Syst Signals"},{"issue":"1","key":"10.1016\/j.jphs.2022.02.005_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-57866-2","article-title":"Structural analysis and optimization of convolutional neural networks with a small sample size","volume":"10","author":"D\u2019souza","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jphs.2022.02.005_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106109","article-title":"Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration\u2013time curve against a trough 15\u201320 \u03bcg\/mL concentration","volume":"56","author":"Oda","year":"2020","journal-title":"Int J Antimicrob Agents"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861322000184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:02:02Z","timestamp":1761163322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861322000184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1347861322000184"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2022.02.005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.16.460731","asserted-by":"object"}]},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A machine learning model that emulates experts\u2019 decision making in vancomycin initial dose planning","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}